D-0097-2018 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- December 6, 2017
- Initiation Date
- November 21, 2017
- Termination Date
- April 15, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 111,648 units
Product Description
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068
Reason for Recall
Failed Dissolution Specification
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: G602051, Exp. 12/2017